Development asset linked to Biotest Farmaceutica Ltda in public FDA and regional records. Molecular target: Focal adhesion kinase 1.
- Target
- Focal adhesion kinase 1
- Mechanism
- Focal adhesion kinase 1 inhibitor
pharma
Biotest Farmaceutica Ltda
Biotest Pharma GmbH
Biotest Farmaceutica Ltda drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Dreieich, DE HQ
2 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Dreieich, DE
- Employees
- 2
- Programs
- 1
- Drugs
- 5
- Patents
- 4
Biotest Farmaceutica Ltda pipeline
Portfolio lens on 5 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Biotest Farmaceutica Ltda drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Biotest Farmaceutica Ltda in public FDA and regional records.
-
Development asset linked to Biotest Farmaceutica Ltda in public FDA and regional records.
-
Development asset linked to Biotest Farmaceutica Ltda in public FDA and regional records.
-
Development asset linked to Biotest Farmaceutica Ltda in public FDA and regional records.